Xvivo System model X2
The 21st Century GMP Quality Platform for processing and producing clinical grade cells.
BioSpherix partners with Sexton Biotechnologies on modular fill-finish for cell and gene therapies
Next Generation Isolators at Canadian Hospitals to begin COVID-19 clinical trials
BioSpherix ramps up production again after COVID pause!
Selecting The Right Isolator For Cell Therapy Manufacturing: Considerations & Challenges
More Cell and Gene Therapy Facilities in the Hundreds are Needed
Point-of-Use Inoculum Prep
ISPE 2019: Closing Down the Process – The Future of Cell and Gene Therapy Manufacturing
Advanced Regenerative Manufacturing Institute (ARMI) New Member Spotlight
BioSpherix Medical Chosen by ACF Bioservices™
Cleanrooms West and BioSpherix Medical Collaboration
Hodess Cleanrooms Installs GMP Isolator Into Wall
Testimonial: Bristol-Myers Squibb
BioSpherix Announces Facility and Capacity Expansion
BioSpherix seen on National Geographic: Miracle Hospital
Could reducing cell manufacturing fluctuations help customers like Novartis improve their cell variability issues for Kymriah?
Institute for Vision Research Announces a Culture System for Human Donor Retina
BioSpherix Sponsors the 2018 ISSCR Meeting in Melbourne!
BioSpherix Medical at ASGCT
BioSpherix Medical at ISCT in Montreal
BioSpherix Medical Announces Successful Completion of F.A.T. Test
BioSpherix Medical will be attending Interphex in NYC
A Short guide to Cell Therapy Manufacturing, Pt. 2
BioSpherix Medical Announces New Partnership
Phacilitate Cell & Gene Therapy conference + World Stem Cell Summit